Edition:
United States

Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

377.46USD
26 May 2017
Change (% chg)

$-7.67 (-1.99%)
Prev Close
$385.13
Open
$386.00
Day's High
$386.00
Day's Low
$377.45
Volume
50
Avg. Vol
858
52-wk High
$389.10
52-wk Low
$276.42

Latest Key Developments (Source: Significant Developments)

Alere says review to complete 2016 annual report on Form 10-K is not complete
Monday, 22 May 2017 09:15am EDT 

May 22 (Reuters) - Alere Inc :Alere announces update on form 10-k and provides preliminary unaudited financial results.Sees fy 2016 gaap loss per share $1.86 from continuing operations.Sees q4 2016 gaap loss per share $1.41 from continuing operations.Sees q1 2017 revenue $588 million.Sees q4 2016 revenue $597 million.Sees fy 2016 revenue $2.38 billion.Says review necessary to complete 2016 annual report on form 10-k is not complete.Alere inc - goal is to complete its review and file its 2016 annual report on form 10-k by no later than june 15, 2017.  Full Article

Greenlight Capital takes share stake in Alere, Micron Technology
Monday, 15 May 2017 04:23pm EDT 

May 15 (Reuters) - Greenlight Capital Inc :Greenlight Capital Inc takes share stake of 1.0 million shares in Alere Inc.Greenlight Capital Inc takes share stake of 1.6 million shares in Micron Technology Inc.Greenlight Capital Inc cuts share stake in Fmc Corp by 53.7 percent to 332,987 shares.Source text for quarter ended March 31, 2017 (http://bit.ly/2qKIyFF) .Source text for quarter ended Dec. 31, 2016: (http://bit.ly/2rj5c45).  Full Article

Alere Inc files for non-timely 10-Q
Thursday, 11 May 2017 05:34pm EDT 

May 11 (Reuters) - Alere Inc ::Alere Inc files for non-timely 10-Q - sec filing.Alere Inc says does not anticipate significant changes in results of operations for quarter ended march 31, 2017 versus quarter ended march 31, 2016.Alere says is reviewing some previously recorded revenue transactions with distributors outside u.s. To evaluate if timing of revenue recognition was appropriate.  Full Article

Alere Inc modifies consent solicitations for notes
Thursday, 4 May 2017 07:00am EDT 

May 4 (Reuters) - Alere Inc :Alere Inc. Announces modifications of consent solicitations for Alere Inc.'s notes.Alere- modifications relating to co's 6.500% senior subordinated notes due 2020,6.375% senior subordinated notes due 2023,7.250% senior notes due 2018.  Full Article

Alere reports commencement of consent solicitations for notes
Monday, 1 May 2017 07:00am EDT 

May 1 (Reuters) - Alere Inc ::Alere Inc. Announces commencement of consent solicitations for alere inc.'s notes.Alere inc. Announces commencement of consent solicitations for alere inc.'s notes.Alere-Commencement of consent solicitations relating to company's 6.500 pct senior subordinated notes due 2020, 6.375 pct senior subordinated notes due 2023.Alere - commencement of consent solicitations relating to company's 7.250 pct senior notes due 2018.  Full Article

Alere Inc enters into third amendment
Monday, 24 Apr 2017 05:49pm EDT 

April 24 (Reuters) - Alere Inc : :Alere Inc - on April 24, co entered into third amendment, dated as of April 24, to secured credit agreement, dated as of June 18, 2015 .Alere Inc - pursuant to third amendment, lenders under credit agreement have agreed to waive certain defaults and events of defaults.Alere Inc - under amendment, lenders agreed to extend deadlines for delivery of financial statements for fiscal year ended December 31, 2016.  Full Article

Alere concluded its financial statements as of Dec 31, 2015 and 2014 should not be relied upon
Monday, 17 Apr 2017 06:00am EDT 

April 17 (Reuters) - Alere Inc :Alere - On April 12, concluded co's financial statements and other financial data as of December 31, 2015 and 2014 should not be relied upon - SEC filing.Alere - preliminarily anticipates that restatements will relate primarily to certain aspects of revenue recognition at co's South Korean location.Alere - on April 12, co also concluded financial statements for years ended Dec 31, 2015, 2014, 2013 should not be relied upon because of misstatements.Alere - also have preliminarily identified revenue recognition error related to one transaction at Japanese location that impacts 2013 and 2012.Alere - Misstatements that caused co to conclude financial statements should not be relied upon related to matters initially identified in late-Jan 2017.Alere - expected that misstatements identified in restatement will not impact total amount of revenue reported related to any transaction.Alere - Review expected to produce revenue adjustment related to 1 transaction in Japan, which resulted in recognition of about $1 million in 2013 instead of 2012.Alere - Based on review, expects that, as of Dec 31, 2016, material weaknesses relating to revenue recognition existing at dec 31, 2015 to be unremediated.Alere- based on its review to date, company will have an additional material weakness related to the control environment at SD.  Full Article

Abbott and Alere amend terms of merger agreement
Friday, 14 Apr 2017 06:00am EDT 

Alere Inc: Abbott and Alere amend terms of merger agreement . Under amended terms, Abbott will pay $51 per common share to acquire Alere . New expected equity value of deal of approximately $5.3 billion, reduced from originally expected equity value of approximately $5.8 billion . Under amended terms, date by which necessary regulatory approvals must be received has been extended to Sept. 30, 2017, from April 30, 2017 .Additionally, companies have agreed to dismiss their respective lawsuits.  Full Article

Abbott Laboratories to buy Alere for $51 per share - FT, citing sources
Friday, 14 Apr 2017 03:08am EDT 

Abbott Laboratories : Abbott laboratories has ended protracted legal battle over its $5 bln plan to buy alere by agreeing to purchase smaller u.s. Rival at a lower price - FT .Abbott will pay $51 a share to acquire the diagnostic testing group instead of the earlier $56-a-share price - FT, citing sources.  Full Article

Alere provides update on Arriva Medical
Thursday, 9 Mar 2017 07:38pm EST 

Alere Inc : Alere provides update on Arriva Medical . Disagree with court's ruling on Arriva's motion for interim relief . Is considering options for appeal .Continues to provide patients with supplies they need as administrative appeal process proceeds.  Full Article

More From Around the Web

BRIEF-Greenlight Capital takes share stake in Alere, Micron Technology

* Greenlight Capital Inc takes share stake of 1.0 million shares in Alere Inc